Gilead Sciences
GILD
#129
Rank
A$227.62 B
Marketcap
A$183.45
Share price
2.00%
Change (1 day)
28.69%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$15.32 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.08 Billion. In 2024 the company made an earning of A$1.03 Billion a decrease over its 2023 earnings that were of A$10.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$15.32 B1377.23%
2024 A$1.03 B-89.94%
2023 A$10.31 B17.97%
2022 A$8.74 B-29.77%
2021 A$12.44 B395.99%
2020 A$2.50 B-67.66%
2019 A$7.75 B-33.84%
2018 A$11.72 B-42.35%
2017 A$20.34 B-20.87%
2016 A$25.70 B-21.06%
2015 A$32.56 B45.8%
2014 A$22.33 B253.01%
2013 A$6.32 B16.51%
2012 A$5.43 B-1.07%
2011 A$5.48 B-6.71%
2010 A$5.88 B11.75%
2009 A$5.26 B29.5%
2008 A$4.06 B19.11%
2007 A$3.41 B-455.74%
2006 -A$0.96 Billion-154.93%
2005 A$1.74 B76.99%
2004 A$0.98 B-266.16%
2003 -A$0.6 Billion-638.24%
2002 A$0.11 B31.5%
2001 A$83.92 M-242.15%
2000 -A$59.05 Million-40.2%
1999 -A$98.73 Million31.85%
1998 -A$74.88 Million8.73%
1997 -A$68.87 Million27.22%
1996 -A$54.13 Million
1994 -A$51.58 Million26.57%
1993 -A$40.75 Million46.49%
1992 -A$27.82 Million362.5%
1991 -A$6.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.39 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.70 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.49 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.49 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.86 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.82 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.71 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.83 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.71 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA